A Phase II Study in Patients With Alopecia Areata

Summary

This is a global Phase 2 study to evaluate the safety and effectiveness of an investigational study drug (called SHR0302) in adults with moderate to severe alopecia areata.

Timeline

Start

2020-05-13

Primary completion

2021-06-10

Completion

2021-06-29

Drugs

Indications